Gene · 5798
Papers3,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoimmune Diseases and Mycobacterial Infection. | Diseases | 2026 | 41892000 | PubTator, text mining | PubMed |
| Comparison of diabetes-related antibody requesting patterns in primary and secondary care in Aotearoa New Zealand: findings from a regional laboratory audit. | J Prim Health Care | 2026 | 41881436 | PubTator, text mining | PubMed |
| Statin prescription rates for prevention of atherosclerotic cardiovascular disease in adults 40-75 years old with type 1 diabetes. | BMJ Open | 2026 | 41857831 | PubTator, text mining | PubMed |
| Adult-Onset Diabetes and Liver Fibrosis as Diagnostic Clues to Alström Syndrome: A Case Report. | Cureus | 2026 | 41798557 | PubTator, text mining | PubMed |
| When Type 2 Diabetes Isn't Type 2: Latent Autoimmune Diabetes in a Lean, Highly Physically Active Adult. | Cureus | 2026 | 41798410 | PubTator, text mining | PubMed |
| Missed Autoimmune Diabetes: Latent Autoimmune Diabetes in Adults in the Setting of Autoimmune Clustering. | Cureus | 2026 | 41777958 | PubTator, text mining | PubMed |
| Focal Hepatic Steatosis Mimicking a Hilar Tumor With Rapid Resolution After Glycemic Control: A Case Report. | Cureus | 2026 | 41773154 | PubTator, text mining | PubMed |
| Comparison of IA-2 Bridge ELISA and Radiobinding Assays for Progression Risk Assessment in Early-Stage Type 1 Diabetes. | Diabetes Obes Metab | 2026 | 41773025 | PubTator, text mining | PubMed |
| Monogenic Neonatal Diabetes: Clinical Presentations, Genetic Findings, and Response to Therapy in a Retrospective Case Series. | Cureus | 2026 | 41769619 | PubTator, text mining | PubMed |
| Two Patients With Extremely Long Type 1 Diabetes Duration With Very Few Complications and Remaining Insulin Secretion. | Clin Case Rep | 2026 | 41767079 | PubTator, text mining | PubMed |
| A Novel Autoimmune Presentation of Wiskott-Aldrich Syndrome: Type 1 Diabetes. | Immun Inflamm Dis | 2026 | 41757399 | PubTator, text mining | PubMed |
| Baseline β-Cell Secretory Reserve and Its Association with Glycaemic Control and Long-Term Outcomes Across Diabetes Phenotypes. | Int J Mol Sci | 2026 | 41752170 | PubTator, text mining | PubMed |
| Early Detection of Pediatric Type 1 Diabetes: The Expanding Role of Screening. | Children (Basel) | 2026 | 41749591 | PubTator, text mining | PubMed |
| Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosis. | Signal Transduct Target Ther | 2026 | 41741410 | PubTator, text mining | PubMed |
| Clinical parameters and emerging biomarkers of partial remission in pediatric type 1 diabetes: a systematic review. | Front Endocrinol (Lausanne) | 2026 | 41737050 | PubTator, text mining | PubMed |
| Evaluation of Clinical, Laboratory and Immunological Characteristics in the Early Onset (Diagnosed Age < 30 Years Old) Patients With Type 2 Diabetes. | J Korean Med Sci | 2026 | 41732045 | PubTator, text mining | PubMed |
| Paralytic Ileus as the Initial Manifestation of New-Onset Type 1 Diabetes Without Diabetic Ketoacidosis: A Case Report. | Cureus | 2026 | 41728451 | PubTator, text mining | PubMed |
| Cardiovascular complications and mortality in patients with youth-onset type 1 and type 2 diabetes: a population-based long-term follow-up study. | BMJ Public Health | 2026 | 41710076 | PubTator, text mining | PubMed |
| In Silico Analysis of the Binding Mode of Verteporfin, a YAP-TEAD Interaction Inhibitor. | Chem Pharm Bull (Tokyo) | 2026 | 41672505 | PubTator, text mining | PubMed |
| Polymorphisms in intron 1 of HLA-DRA differentially associate with type 1 diabetes and celiac disease and implicate involvement of complement system genes C4A and C4B. | Elife | 2026 | 41627183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5798/papers?page=2